Winan J. van Houdt

机构：Dutch Cancer Society, The Netherlands Cancer Institute, Oncode Institute, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital · ORCID：0000-0002-2303-3468

发表论文 384 篇 · 总被引 19413 次 · h-index 53

代表论文

• Tumour-reactive heterotypic CD8 T cell clusters from clinical samples (2025 · Nature · 被引 20)
• Neoadjuvant ipilimumab and nivolumab in resectable cutaneous squamous cell carcinoma: a randomized phase 2 trial (2025 · Nature Medicine · 被引 13)
• Small round cell sarcoma tumoroid biobank reveals CIC::DUX4 sarcoma vulnerability to MCL-1 inhibition (2025 · Nature Communications · 被引 11)
• How to foster new treatment development in ultra-rare tumours? Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancers (2025 · Cancer Treatment Reviews · 被引 9)
• Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial (2026 · Nature Medicine · 被引 7)
• Evaluation of Diagnostic Accuracy of Preoperative CT-Based Radiomics in Primary Retroperitoneal Sarcoma (2025 · Annals of Surgical Oncology · 被引 7)